Published in Obstet Gynecol on July 01, 1996
The Navigation Guide - evidence-based medicine meets environmental health: integration of animal and human evidence for PFOA effects on fetal growth. Environ Health Perspect (2014) 1.14
Isomer profiles of perfluorochemicals in matched maternal, cord, and house dust samples: manufacturing sources and transplacental transfer. Environ Health Perspect (2011) 0.90
Maternal hemoglobin concentration and its association with birth weight in newborns of mothers with preeclampsia. J Matern Fetal Neonatal Med (2009) 0.86
Effects of vivax malaria acquired before 20 weeks of pregnancy on subsequent changes in fetal growth. Am J Trop Med Hyg (2014) 0.85
Serum 25-hydroxyvitamin D is not related to cardiac natriuretic peptide in nulliparous and lactating women. BMC Endocr Disord (2009) 0.77
Changes in maternal hemoglobin during pregnancy and birth outcomes. BMC Pregnancy Childbirth (2015) 0.77
Gestation-Specific Changes in the Anatomy and Physiology of Healthy Pregnant Women: An Extended Repository of Model Parameters for Physiologically Based Pharmacokinetic Modeling in Pregnancy. Clin Pharmacokinet (2017) 0.75
Maternal haemoglobin concentrations before and during pregnancy and stillbirth risk: a population-based case-control study. BMC Pregnancy Childbirth (2016) 0.75
Preliminary validation of an exercise program suitable for pregnant women with abnormal glucose metabolism: inhibitory effects of Tai Chi Yuttari-exercise on plasma glucose elevation. J Phys Ther Sci (2016) 0.75
Changes in Circulating ProAMH and Total AMH during Healthy Pregnancy and Post-Partum: A Longitudinal Study. PLoS One (2016) 0.75
Can anemia predict perinatal outcomes in different stages of pregnancy? Pak J Med Sci (2017) 0.75
Validation of a food-frequency questionnaire for assessing vitamin intake of Japanese women in early and late pregnancy with and without nausea and vomiting. J Nutr Sci (2016) 0.75
Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man. Gut (1983) 3.46
Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther (2009) 2.11
Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother (1999) 2.07
Magnetic resonance imaging pelvimetry: a useful adjunct in the management of the obese patient. Br J Obstet Gynaecol (1992) 2.02
Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative. Aliment Pharmacol Ther (2003) 1.91
Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD study. Aliment Pharmacol Ther (2011) 1.76
Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole. Am J Gastroenterol (1999) 1.74
Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet (1974) 1.71
Effects of substituted benzimidazole (H 149/94) on gastric acid secretion in humans. Gastroenterology (1982) 1.66
The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole. Aliment Pharmacol Ther (2004) 1.64
Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study. Dig Liver Dis (2006) 1.57
The epidemiology of shoulder dislocations. Arch Orthop Trauma Surg (1989) 1.53
Maternal body mass index in early pregnancy and offspring asthma, rhinitis and eczema up to 16 years of age. Clin Exp Allergy (2015) 1.53
Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies. Aliment Pharmacol Ther (2015) 1.51
Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population--the Kalixanda study. Aliment Pharmacol Ther (2006) 1.49
Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study. J Clin Epidemiol (2004) 1.47
Antenatal screening for diabetes mellitus. Br J Obstet Gynaecol (1984) 1.47
The EXT1/EXT2 tumor suppressors: catalytic activities and role in heparan sulfate biosynthesis. EMBO Rep (2000) 1.41
A serial study of changes occurring in the oral glucose tolerance test during pregnancy. J Obstet Gynaecol Br Commonw (1973) 1.41
Development and comorbidity of eczema, asthma and rhinitis to age 12: data from the BAMSE birth cohort. Allergy (2012) 1.41
Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study. Aliment Pharmacol Ther (2003) 1.40
Omeprazole in Zollinger-Ellison syndrome. Effects of a single dose and of long-term treatment in patients resistant to histamine H2-receptor antagonists. N Engl J Med (1984) 1.36
Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study. Scand J Gastroenterol (1997) 1.36
Fetal heart rate monitoring during labour--too frequent intervention, too little benefit? Lancet (1987) 1.36
Red cell mass during and after normal pregnancy. Br J Obstet Gynaecol (1979) 1.28
Changes in serum uric acid concentrations during normal pregnancy. Br J Obstet Gynaecol (1984) 1.26
New index for evaluation of oral glucose tolerance test results. Br Med J (1973) 1.17
Observations on blood glucose and insulin determinations. Br Med J (1972) 1.16
Interphotoreceptor retinoid-binding protein and alpha-tocopherol preserve the isomeric and oxidation state of retinol. Photochem Photobiol (1992) 1.15
The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. Aliment Pharmacol Ther (1999) 1.13
Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine. Scand J Gastroenterol (1991) 1.12
Characterization of the glycosyltransferase enzyme from the Escherichia coli K5 capsule gene cluster and identification and characterization of the glucuronyl active site. J Biol Chem (1998) 1.11
Systematic review: proton pump inhibitors (PPIs) for the healing of reflux oesophagitis - a comparison of esomeprazole with other PPIs. Aliment Pharmacol Ther (2006) 1.09
Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months. Aliment Pharmacol Ther (2001) 1.09
The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer. Aliment Pharmacol Ther (1999) 1.08
Prevention and treatment of experimental autoimmune encephalomyelitis by CNI-1493, a macrophage-deactivating agent. J Immunol (1998) 1.07
Unsuspected pregnancy loss in healthy women. Lancet (1983) 1.07
Observations on the oral glucose tolerance test in pregnancy. J Obstet Gynaecol Br Commonw (1968) 1.06
Endocrine cells in the human oxyntic mucosa. A histochemical study. Scand J Gastroenterol (1988) 1.06
Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease -- results from a randomized trial programme. Aliment Pharmacol Ther (2002) 1.05
The effects of oral iron supplementation on zinc and magnesium levels during pregnancy. Br J Obstet Gynaecol (1985) 1.05
Effect of iron supplementation on serum ferritin levels during and after pregnancy. Br J Obstet Gynaecol (1982) 1.04
Suppressor T cells activated in a primary in vitro response to non-major histocompatibility alloantigens. J Exp Med (1982) 1.04
Biochemical and cytological changes in liquor amnii with advancing gestation. J Obstet Gynaecol Br Commonw (1969) 1.03
Specific neonatally induced tolerance to Mls locus determinants. J Immunol (1985) 1.00
Haematological changes during normal pregnancy: iron induced macrocytosis. Br J Obstet Gynaecol (1976) 1.00
Relation between birth-weight and rupture-delivery interval. Lancet (1969) 0.99
The excretion of glucose during normal pregnancy. J Obstet Gynaecol Br Commonw (1972) 0.97
The HOMER Study: the effect of increasing the dose of metronidazole when given with omeprazole and amoxicillin to cure Helicobacter pylori infection. Helicobacter (2000) 0.97
Absorption of non-haem iron from food during normal pregnancy. BMJ (1994) 0.97
Does random blood glucose sampling outdate testing for glycosuria in the detection of diabetes during pregnancy? Br Med J (Clin Res Ed) (1984) 0.96
Metabolic changes in pregnancy relevant to diabetes mellitus. Postgrad Med J (1979) 0.95
Generation of primary cytotoxic lymphocytes against non-major histocompatibility complex antigens by anti-Ia serum plus complement-treated lymphocytes. J Exp Med (1980) 0.94
The intravascular mass of albumin during human pregnancy: a serial study in normal and diabetic women. Br J Obstet Gynaecol (1993) 0.94
Effect of normal pregnancy upon the glycosylated haemoglobins. Br J Obstet Gynaecol (1979) 0.94
Primary in vitro cytotoxic T cell response to non-major histocompatibility complex alloantigens in normal mice. J Exp Med (1982) 0.94
Systematic review: standard- and double-dose proton pump inhibitors for the healing of severe erosive oesophagitis -- a mixed treatment comparison of randomized controlled trials. Aliment Pharmacol Ther (2009) 0.93
BMI at 4 years of age is associated with previous and current protein intake and with paternal BMI. Eur J Clin Nutr (2009) 0.92
Health-related quality of life in patients with gastro-oesophageal reflux disease under routine care: 5-year follow-up results of the ProGERD study. Aliment Pharmacol Ther (2009) 0.91
Antenatal screening for diabetes mellitus by random blood glucose sampling. Br J Obstet Gynaecol (1981) 0.91
Medical or surgical management of GERD patients with Barrett's esophagus: the LOTUS trial 3-year experience. J Gastrointest Surg (2008) 0.91
Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response? Aliment Pharmacol Ther (2007) 0.90
A prospective study to compare serum human placental lactogen and menstrual dates for determining gestational age. Am J Obstet Gynecol (1987) 0.90
Independent inhibition of IL 2 synthesis and cell proliferation by anti-Ia antibodies in mixed lymphocyte responses to Mls. Eur J Immunol (1984) 0.90
Palliative endoscopic dilatation in carcinoma of the esophagus and esophagogastric junction. Acta Chir Scand (1989) 0.89
Laryngeal atresia or stenosis presenting as second-trimester fetal ascites--diagnosis and pathology in three independent cases. Prenat Diagn (1998) 0.89
Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonists. Aliment Pharmacol Ther (1990) 0.89
Changes in serum immunoreactive erythropoietin during the menstrual cycle and normal pregnancy. Br J Obstet Gynaecol (1983) 0.88
Daily treatment with esomeprazole is superior to that taken on-demand for maintenance of healed erosive oesophagitis. Aliment Pharmacol Ther (2005) 0.88
Planned pregnancy in a renal transplant recipient. Br J Obstet Gynaecol (1976) 0.88
A prospective, controlled trial of six forms of hormone replacement therapy given to postmenopausal women. Br J Obstet Gynaecol (1979) 0.88
The role of the fetus in the formation of amniotic fluid. J Obstet Gynaecol Br Commonw (1972) 0.88
Effect of adductor canal block on pain in patients with severe pain after total knee arthroplasty: a randomized study with individual patient analysis. Br J Anaesth (2014) 0.88
Effect of omeprazole on gastric acid secretion and plasma gastrin in man. Scand J Gastroenterol Suppl (1989) 0.87
Platelet values during normal pregnancy. Br J Obstet Gynaecol (1985) 0.87
Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro-oesophageal reflux disease: a matched case-control study. Aliment Pharmacol Ther (2008) 0.86
What parameters are relevant for the histological diagnosis of gastroesophageal reflux disease without Barrett's mucosa? Dig Dis (2004) 0.86
Insulin disappearance rate in pregnant and non-pregnant women, and in non-pregnant women given GHRIH. Eur J Clin Invest (1977) 0.86
Systematic review of proton pump inhibitors for the acute treatment of reflux oesophagitis. Aliment Pharmacol Ther (2001) 0.86
Composition of amniotic fluid and maternal blood through pregnancy. J Obstet Gynaecol Br Commonw (1971) 0.86
Is pregnancy safe after uterine artery embolisation? BJOG (2012) 0.86
Intravenous omeprazole: effect on 24-hour intragastric pH in duodenal ulcer patients. Digestion (1986) 0.85
Diet intake and caries prevalence in four-year-old children living in a low-prevalence country. Caries Res (2007) 0.85
The limitations of ultrasonic fetal cephalometry. J Obstet Gynaecol Br Commonw (1973) 0.85
The link between parental allergy and offspring allergic and nonallergic rhinitis. Allergy (2013) 0.84
Sufficient control of heartburn in endoscopy-negative gastro-oesophageal reflux disease trials. Scand J Gastroenterol (2003) 0.84
Cost-of-disease analysis in patients with gastro-oesophageal reflux disease and Barrett's mucosa. Aliment Pharmacol Ther (2006) 0.84
Nutrient requirements during pregnancy--I. Am J Clin Nutr (1981) 0.84
Letter: How does danazol work? Lancet (1976) 0.83
One-week triple therapy with esomeprazole provides effective eradication of Helicobacter pylori in duodenal ulcer disease. Aliment Pharmacol Ther (2000) 0.83
Puerperal haematological indices. Br J Obstet Gynaecol (1981) 0.82
Accidental third-degree burn caused by bipolar electrocoagulation. Injury (1995) 0.82
Comparison of once-daily intravenous and oral omeprazole on pentagastrin-stimulated acid secretion in duodenal ulcer patients. Digestion (1992) 0.82
V beta-specific activation of T cells by the HIV glycoprotein gp 160. Scand J Immunol (1995) 0.82
Non-H-2 T-lymphocyte-mediated cytotoxicity after primary in vivo sensitization. Scand J Immunol (1980) 0.82
Purification and characterization of fetal bovine serum beta-N-acetyl-D-galactosaminyltransferase and beta-D-glucuronyltransferase involved in chondroitin sulfate biosynthesis. Eur J Biochem (1999) 0.81